EUVIMEDEUVIMED entdecken
VergleichsstudieKohortenstudie

Comparative effectiveness of curettage, uterine artery embolization, and gonadotropin‐releasing hormone ( GnRH ) agonist therapy in the management of acquired uterine enhanced myometrial vascularity/arteriovenous malformation ( EMV / AVM ) and retained products of conception ( RPOC ): A retrospective cohort study

Amin Abolhasani Foroughi, Seyed Sina Dehghani iD, Zahra Shiravani, Mehran Mansoori

International Journal of Gynecology & Obstetrics · 2026

DOI: 10.1002/ijgo.71010 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift International Journal of Gynecology & Obstetrics, 2026. Verfasst von Amin Abolhasani Foroughi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medical Imaging Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. Hauptthemen laut MEDLINE: Gonadotropin-Releasing Hormone, Arteriovenous Malformations, Uterine Artery Embolization, Myometrium. Die Arbeit nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To compare the effectiveness of curettage, uterine artery embolization (UAE), and gonadotropin‐releasing hormone (GnRH) agonist therapy in the management of post‐abortion acquired uterine enhanced myometrial vascularity/arteriovenous malformation (EMV/AVM) with retained products of conception (RPOC), focusing on short‐term healing and reproductive outcomes.

Methods

This monocentric retrospective cohort study included 159 women with EMV/AVM associated with RPOC after abortion, treated at a tertiary referral center affiliated with Shiraz University of Medical Sciences between January 2022 and December 2025. Patients underwent curettage, UAE with polyvinyl alcohol (PVA) particles, or GnRH agonist therapy. Outcomes included EMV/AVM healing and RPOC resolution at 4 weeks, change in RPOC volume, subsequent pregnancy, and recurrent abortion. Analyses were performed in SPSS version 26.0 with a two‐sided significance threshold of P less than 0.05, following STROBE guidelines.

Results

At 4 weeks, AVM healing occurred in 70.2% and RPOC resolution in 68.4% of patients. Curettage and UAE achieved significantly higher rates of EMV/AVM and RPOC healing than GnRH agonist therapy ( P = 0.018 and P = 0.013, respectively). No significant between‐group differences were observed for subsequent pregnancy ( P = 0.933) or recurrent abortion ( P = 0.065).

Conclusion

Curettage and UAE provide superior short‐term healing compared with GnRH agonist therapy, while reproductive outcomes appear comparable across modalities. Treatment selection should consider Doppler parameters, clinical stability, and fertility goals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gonadotropin-Releasing HormoneArteriovenous MalformationsUterine Artery EmbolizationMyometriumCurettageHumansFemaleRetrospective StudiesAdultPregnancyTreatment OutcomeUterus

Stichwörter der Autor:innen

Doppler ultrasonographyfertility preservationgonadotropin‐releasing hormone agonistreproductive outcomesretained products of conceptionuterine arteriovenous malformationuterine artery embolizationuterine curettage

Substanzen

Gonadotropin-Releasing Hormone

Autor:innen und Institutionen

  • Medical Imaging Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Medical Imaging Research Center, Department of Radiology, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Department of Obstetrics and Gynecology, Division of Oncology Gynecology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Department of Radiology, Shiraz University of Medical Sciences, Shiraz, Iran.

ORCID-Profile: Seyed Sina Dehghani

Zitieren

APA

Foroughi, A. A., Dehghani, S. S., Shiravani, Z., & Mansoori, M. (2026). Comparative effectiveness of curettage, uterine artery embolization, and gonadotropin‐releasing hormone ( GnRH ) agonist therapy in the management of acquired uterine enhanced myometrial vascularity/arteriovenous malformation ( EMV / AVM ) and retained products of conception ( RPOC ): A retrospective cohort study. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.71010

Vancouver

Foroughi AA, Dehghani SS, Shiravani Z, Mansoori M. Comparative effectiveness of curettage, uterine artery embolization, and gonadotropin‐releasing hormone ( GnRH ) agonist therapy in the management of acquired uterine enhanced myometrial vascularity/arteriovenous malformation ( EMV / AVM ) and retained products of conception ( RPOC ): A retrospective cohort study. International Journal of Gynecology & Obstetrics. 2026. doi:10.1002/ijgo.71010

BibTeX
@article{Foroughi2026,
  author = {Foroughi, Amin Abolhasani and Dehghani, Seyed Sina and Shiravani, Zahra and Mansoori, Mehran},
  title = {Comparative effectiveness of curettage, uterine artery embolization, and gonadotropin‐releasing hormone ( GnRH ) agonist therapy in the management of acquired uterine enhanced myometrial vascularity/arteriovenous malformation ( EMV / AVM ) and retained products of conception ( RPOC ): A retrospective cohort study},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2026},
  doi = {10.1002/ijgo.71010}
}
Kostenlos starten →